Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

Clinical trial NCT05519449 · RECRUITING

Trial details

NCT number: NCT05519449
Sponsor: Janux Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer Metastatic Castration-resistant Prostate Cancer Castration Resistant Prostatic Cancer

Start date: 2022-09-15
Primary completion: 2027-07-01
Enrollment: 272

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.